Company / Working Capital per Share
Twist Bioscience Corp Working Capital per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$4.04
FY2025
5-year range
$4.04 / $10.02
FY2021-FY2025
Trend
-15.0%
vs FY2024
Sector context
#126 of 212
Health Care
What the data says
At $4.04, Twist Bioscience Corp's working capital per share ranks #126 of 212 in the Health Care sector. Working Capital per Share has declined for 4 consecutive years, from $10.02 in FY2021 to $4.04 in FY2025.
Based on SEC 10-K filings.
4.04 in FY2025 with a 5-year CAGR of -11.9%.
Declined from $6.17 to $4.04 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -24.5%
- 5-Year CAGR
- -11.9%
- 10-Year CAGR
- -
Sector benchmark
#126 of 212 in Health CareTop 59% of 212This company $4.04 Sector average $117.56
▼
-96.6% below sector average
Key checks
Key Insights
- Twist Bioscience Corp's working capital per share has declined for 4 consecutive years.
- In FY2025, working capital per share decreased 15.0% year-over-year.
- Ranks #126 out of 212 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.04 | -15.0% |
| FY2024 | $4.75 | -22.9% |
| FY2023 | $6.17 | -34.3% |
| FY2022 | $9.39 | -6.3% |
| FY2021 | $10.02 | +31.4% |
| FY2020 | $7.63 | +61.4% |
| FY2019 | $4.73 | -100.0% |
| FY2018 | $27616.90 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026